Kubota Glasses technology works to reduce the increase in axial length associated with myopia by projecting myopically-defocused virtual images generated using micro-LEDS on the peripheral visual field to actively stimulate the retina. Passive stimulation using myopic defocus is already in use in the US with a contact lens, “MiSight^® 1 day” by CooperVision, which is U.S. Food and Drug Administration (FDA) approved to slow the progression of
myopia. This product, which uses multifocal contact lens technology, passively stimulates the entire peripheral retina with light myopically defocused by the
non-central power of the contact lens. Kubota Glasses technology leverages nanotechnology in its electronic glasses-based device and seeks to reduce the progression of
myopia by actively stimulating the retina for shorter periods
while maintaining high-quality central vision and not affecting daily activities.
Strip the jargon away and this sounds like it's saying "wear weaker glasses" and the device is just a fancy way to still see normally while having a weaker prescription in your periphery?
Anecdotally, among a bunch of my friends who are (a) nearsighted, and (b) mad about sailing ships, spending a couple of weeks out at sea staring at the horizon will make a significant temporary difference to their myopia.
I don't know why sibling poster is dead, it seems a fair question and I didn't know the answer so I've asked them and will update when I get a reply.
Edit: The person I asked said they wore their glasses some of the time but also spent some of the time without (when they were climbing in the rigging etc.)
Maybe there is a difference between active and passive retina stimulation in terms of ability to correct myopia? From the article it sounds like they are still determining if they can actually cure myopia and how long the effect lasts. Of course, at least in the US, how they are able to market them depends on what they get FDA approval for.
I read this as "We stuck a ring of LED's around some glasses based on some flimsy science. The glasses cost $0.50 to make, yet we can sell them for $10k a pair.".
Kubota Glasses technology works to reduce the increase in axial length associated with myopia by projecting myopically-defocused virtual images generated using micro-LEDS on the peripheral visual field to actively stimulate the retina. Passive stimulation using myopic defocus is already in use in the US with a contact lens, “MiSight^® 1 day” by CooperVision, which is U.S. Food and Drug Administration (FDA) approved to slow the progression of myopia. This product, which uses multifocal contact lens technology, passively stimulates the entire peripheral retina with light myopically defocused by the non-central power of the contact lens. Kubota Glasses technology leverages nanotechnology in its electronic glasses-based device and seeks to reduce the progression of myopia by actively stimulating the retina for shorter periods while maintaining high-quality central vision and not affecting daily activities.